Microbiome-immune interactions and relationship to asthma severity - 03/02/22
Doi : 10.1016/j.jaci.2021.12.774
Juan Trujillo, MD, MSc a, Nonhlanhla Lunjani, MD b, c, Dermot Ryan, MD, FRCGP d, Liam O’Mahony, PhD b, e, f, ⁎ 
a Cork University Hospital, Irish Centre for Maternal and Child Health Research (INFANT), HRB Clinical Research Facility Cork, Cork, Ireland
b APC Microbiome Ireland, University College Cork, Cork, Ireland
c Department of Dermatology, University of Cape Town, South Africa
d Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom
e Department of Medicine, University College Cork, Cork, Ireland
f School of Microbiology, University College Cork, Cork, Ireland
∗Corresponding author: Liam O’Mahony, PhD, Department of Medicine and School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.Department of Medicine and School of MicrobiologyAPC Microbiome IrelandUniversity College CorkCorkIreland
Key words : Microbiome, microbiota, severe asthma, inflammation
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: L. O’Mahony has participated in speakers’ bureaus for Nestle, Nutricia, Reckitt, and Abbott; he is a consultant to PrecisionBiotics; and he has received research funding from GSK and Chiesi. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2021
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 149 - N° 2
P. 533-534 - février 2022 Retour au numéro
Article précédent
- News Beyond Our Pages
- Marc E. Rothenberg, Jean Bousquet
- Moving beyond medication: Assessment and interventions on environmental and social determinants are needed to reduce severe asthma
- Erika Garcia, Frank Gilliland
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?